Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Solute carrier family 12 member 6 (SLC12A6) mutations have been found to be responsible for the phenotype that causes agenesis of the corpus callosum (CC) with peripheral neuropathy, a condition which is also known as Andermann syndrome (AS). AS is an autosomal-recessive disease with syndromic features that has rarely been reported anywhere in the world other than Quebec, Canada.1 Hereditary neuropathies (HN) and complicated hereditary spastic paraparesis (HSP) call for differential diagnosis, since AS has both neurodevelopmental and neurodegenerative aspects affecting both sensory and motor fibres.1 2 This study presents an AS family who has motor neuropathy without sensory involvement due to a new SLC12A6 mutation.
Patient 1 is a 17-year-old man of a first degree cousin marriage. He had hypotonia at birth. At the age of 2 years, he could walk independently, but after 3, he had difficulty in walking, which worsened in years to follow. He suffered from mild mental retardation, had phenotypic long face, hypoplastic maxilla, minimal bilateral ptosis (figure 1) and high-arched palate. Long tapered fingers were remarkable (figure 1). He had thoracic scoliosis and flexion contracture in both ankles. Symmetrical reduced muscle strength and atrophy existed in the proximal and distal muscles, which were more prominent in the lower extremities. Plantar reflex was noted to be extensor, and deep tendon reflexes could be detected. Electromyography (EMG) examination showed that sensory transmissions were normal, but …
NHA and ZY contributed equally.
Contributors NHA and ZY: substantially contributed to design of the manuscript. NHA, ZY and ANB gave final approval of manuscript. All authors: contributed to analysis and interpretation of data and critically revised manuscript for the content of the study.
Funding Suna and İnan Kıraç Foundation.
Competing interests None declared.
Patient consent Guardian consent obtained.
Ethics approval Ethical approval for this study has been obtained from the Local Ethics Committee of Istanbul University.
Provenance and peer review Not commissioned; externally peer reviewed.